Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Castelli

Showing results (361-370 of 425) with videos related to

Pageof 43
Sort By:
Medicine|July 22, 2016
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort studyEmanuele Focà, Massimiliano Fabbiani, Mattia Prosperi, et al.
Plos One|October 13, 2021
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohortEmanuele Focà, Andrea Calcagno, Stefano Calza, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 22, 2015
West Nile virus outbreak in the Lombardy region, northern Italy, summer 2013Francesca Rovida, Antonella Sarasini, Giulia Campanini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) studyLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.
Annals of Neurology|May 18, 2020
Steroid-Responsive Encephalitis in Coronavirus Disease 2019Andrea Pilotto, Silvia Odolini, Stefano Masciocchi, et al.
Le Infezioni in Medicina|June 1, 2021
Valacyclovir for prevention and treatment of fetal CMV infection: inclusion in the Law 648/96 list and launch of the Italian multicentre observational prospective study "MEGAL-ITALI"Lorenzo Zammarchi, Tiziana Lazzarotto, Mariarosaria Di Tommaso, et al.
The Lancet. HIV|February 25, 2018
Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trialAlan Winston, Frank A Post, Edwin DeJesus, et al.
Clinical and Experimental Gastroenterology|December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infectionChristoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2024
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 TrialOnyema Ogbuagu, Jean-Michel Molina, Ploenchan Chetchotisakd, et al.
Vaccine|February 14, 2024
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infectionFrancesco Donato, Andrea Pilotto, Emanuele Focà, et al.
Pageof 43

Showing results (361-370 of 425) with videos related to

Sort By:
Pageof 43
Medicine|July 22, 2016
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort studyEmanuele Focà, Massimiliano Fabbiani, Mattia Prosperi, et al.
Plos One|October 13, 2021
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohortEmanuele Focà, Andrea Calcagno, Stefano Calza, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 22, 2015
West Nile virus outbreak in the Lombardy region, northern Italy, summer 2013Francesca Rovida, Antonella Sarasini, Giulia Campanini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) studyLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.
Annals of Neurology|May 18, 2020
Steroid-Responsive Encephalitis in Coronavirus Disease 2019Andrea Pilotto, Silvia Odolini, Stefano Masciocchi, et al.
Le Infezioni in Medicina|June 1, 2021
Valacyclovir for prevention and treatment of fetal CMV infection: inclusion in the Law 648/96 list and launch of the Italian multicentre observational prospective study "MEGAL-ITALI"Lorenzo Zammarchi, Tiziana Lazzarotto, Mariarosaria Di Tommaso, et al.
The Lancet. HIV|February 25, 2018
Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trialAlan Winston, Frank A Post, Edwin DeJesus, et al.
Clinical and Experimental Gastroenterology|December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infectionChristoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2024
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 TrialOnyema Ogbuagu, Jean-Michel Molina, Ploenchan Chetchotisakd, et al.
Vaccine|February 14, 2024
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infectionFrancesco Donato, Andrea Pilotto, Emanuele Focà, et al.
Pageof 43